Washington, DC, United States of America

Ginger Johnson


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal1 out of 832,680 
Other
 patents

Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator in Neuroscience: Ginger Johnson

Introduction: Ginger Johnson is a distinguished inventor based in Washington, DC, who has made significant contributions to the field of neuroscience through her innovative work on diagnostic methods. With a focus on identifying biomarkers for neurodegenerative diseases, she holds a notable patent that addresses critical issues in mental health diagnostics.

Latest Patents: Ginger Johnson is credited with a patent that revolves around "Diagnosing Alzheimer's disease and schizophrenia." This patent describes a method for detecting elevated levels of the middle isoform of alpha-2 haptoglobin and alpha-2FS haptoglobin in bodily fluids. By comparing these levels with those found in normal subjects, her work provides a potential diagnostic marker for both Alzheimer's disease and schizophrenia. Additionally, the presence of fibrinogen fragments corresponding to proteins 127 and 128 in elevated levels serves as further evidence supporting her diagnostic approach.

Career Highlights: Ginger has dedicated her career to advancing medical diagnostics, particularly within the realm of neurodegenerative diseases. Her innovative approach has positioned her as a leader in her field, showcasing her ability to bridge the gap between scientific research and practical application. With only one patent to her name, her impact is profound, as it addresses critical health issues faced by countless individuals.

Collaborations: Throughout her journey, Ginger Johnson has collaborated with prominent professionals, including Carl R. Merril and Hossein A. Ghanbari. These partnerships have enabled her to enhance her research and combine expertise in the pursuit of groundbreaking solutions in the field of neuroscience.

Conclusion: Ginger Johnson's innovative work in diagnosing Alzheimer's disease and schizophrenia represents a significant advancement in medical diagnostics. Her patent not only contributes to scientific knowledge but also holds the potential to improve the quality of life for patients afflicted by these challenging conditions. With her continued dedication to research, Ginger remains an inspiring figure in the realm of medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…